FINISHED DOSAGE FORMULATIONS
POLOXAMER 407
Route : INTRATYMPANIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 15.1
Potency Unit : %W/W

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.2
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : OPHTHALMIC
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.1
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 0.9
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 1
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 40
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 5
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 126
Potency Unit : MG/25.169GM

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
POLOXAMER 407
Route : ORAL
CAS : 691397-13-4
UNII : TUF2IVW3M2
Potency Amount : 50
Potency Unit : MG/5ML

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE